{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:48:43Z","timestamp":1785296923160,"version":"3.55.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,28]],"date-time":"2021-12-28T00:00:00Z","timestamp":1640649600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","award":["848018008"],"award-info":[{"award-number":["848018008"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.sapharm.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T01:47:15Z","timestamp":1640396835000},"page":"3329-3337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Key factors underlying the willingness of patients with cancer to participate in medication redispensing"],"prefix":"10.1016","volume":"18","author":[{"given":"E.M.","family":"Smale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.C.G.","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"Heerdink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.F.","family":"van den Bemt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.sapharm.2021.12.004_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2114-5","article-title":"Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review","volume":"134","author":"Murphy","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.sapharm.2021.12.004_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1078155213520261","article-title":"Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia","volume":"21","author":"Anderson","year":"2015","journal-title":"J Oncol Pharm Pract"},{"issue":"9","key":"10.1016\/j.sapharm.2021.12.004_bib3","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/14740338.2019.1641197","article-title":"Oral antineoplastic agents: assessment of safety and dose adjustments in clinical practice","volume":"18","author":"Escudero-Vilaplana","year":"2019","journal-title":"Expet Opin Drug Saf"},{"issue":"27","key":"10.1016\/j.sapharm.2021.12.004_bib4","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1200\/JCO.2009.25.9655","article-title":"Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients","volume":"28","author":"Hershman","year":"2010","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.sapharm.2021.12.004_bib5","first-page":"1457","article-title":"Treatment utilization patterns of newly initiated oral anticancer agents in a national sample of Medicare beneficiaries","volume":"27","author":"Doshi","year":"2021","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2021.12.004_bib6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.sapharm.2018.03.064","article-title":"Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy","volume":"15","author":"Bekker","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2021.12.004_bib7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jclepro.2018.11.204","article-title":"Carbon footprint of the global pharmaceutical industry and relative impact of its major players","volume":"214","author":"Belkhir","year":"2019","journal-title":"J Clean Prod"},{"key":"10.1016\/j.sapharm.2021.12.004_bib8","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1897\/09-073.1","article-title":"Contamination of surface, ground, and drinking water from pharmaceutical production","volume":"28","author":"Fick","year":"2009","journal-title":"Environ Toxicol Chem\/SETAC"},{"key":"10.1016\/j.sapharm.2021.12.004_bib9","first-page":"71","article-title":"Disposal of unused drugs: knowledge and behavior among people around the world","volume":"240","author":"Kusturica","year":"2016","journal-title":"Rev Environ Contam Toxicol"},{"key":"10.1016\/j.sapharm.2021.12.004_bib10","series-title":"Pricing of Cancer Medicines and its Impact","author":"World Health Organization","year":"2018"},{"issue":"7","key":"10.1016\/j.sapharm.2021.12.004_bib11","doi-asserted-by":"crossref","first-page":"e646","DOI":"10.1200\/JOP.2017.022905","article-title":"Financial impact of cancer drug wastage and potential cost savings from mitigation strategies","volume":"13","author":"Leung","year":"2017","journal-title":"J Oncol Pract"},{"issue":"4","key":"10.1016\/j.sapharm.2021.12.004_bib12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/1078155218762596","article-title":"Financial impact of oral chemotherapy wastage on society and the patient","volume":"25","author":"Monga","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.sapharm.2021.12.004_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1472-6963-8-70","article-title":"Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study","volume":"8","author":"Fasola","year":"2008","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.sapharm.2021.12.004_bib14","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s11096-020-01083-4","article-title":"Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines","volume":"42","author":"Matti","year":"2020","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2021.12.004_bib15","doi-asserted-by":"crossref","first-page":"100400","DOI":"10.1016\/j.scp.2021.100400","article-title":"Waste-minimising measures to achieve sustainable supply and use of medication","volume":"20","author":"Smale","year":"2021","journal-title":"Sustainable Chemistry and Pharmacy"},{"issue":"4","key":"10.1016\/j.sapharm.2021.12.004_bib16","article-title":"Can we create a circular pharmaceutical supply chain (CPSC) to reduce medicines waste?","volume":"8","author":"Alshemari","year":"2020","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.sapharm.2021.12.004_bib17","author":"Stam"},{"key":"10.1016\/j.sapharm.2021.12.004_bib18","series-title":"Pharmaceutical Waste Reduction in the NHS","author":"Hazell","year":"2015"},{"issue":"4","key":"10.1016\/j.sapharm.2021.12.004_bib19","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.sapharm.2014.10.003","article-title":"Taking stock of medication wastage: unused medications in US households","volume":"11","author":"Law","year":"2015","journal-title":"Res Soc Adm Pharm"},{"issue":"14","key":"10.1016\/j.sapharm.2021.12.004_bib21","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.2146\/news050007","article-title":"Oklahoma allows limited medication recycling: program aims to help indigent patients","volume":"62","author":"Thompson","year":"2005","journal-title":"Am J Health Syst Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2021.12.004_bib22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1331\/JAPhA.2014.11101","article-title":"Operation Donate: defining the value of redispensing medications donated by individuals","volume":"54","author":"Glanville","year":"2003","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/j.sapharm.2021.12.004_bib23","series-title":"State Prescription Drug Return, Reuse and Recycling Laws","author":"Cauchi","year":"2018"},{"issue":"6","key":"10.1016\/j.sapharm.2021.12.004_bib24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/ijpp.12275","article-title":"The redistribution of medicines: could it become a reality?","volume":"24","author":"McRae","year":"2016","journal-title":"Int J Pharm Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2021.12.004_bib25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s11096-017-0424-8","article-title":"Redispensing of medicines unused by patients: a qualitative study among stakeholders","volume":"39","author":"Bekker","year":"2017","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2021.12.004_bib26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/ijpp.12391","article-title":"How do people conceptualise the reuse of medicines? An interview study","volume":"26","author":"Alhamad","year":"2018","journal-title":"Int J Pharm Pract"},{"issue":"11","key":"10.1016\/j.sapharm.2021.12.004_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/s20113080","article-title":"Enabling medicine reuse using a digital time temperature humidity sensor in an internet of pharmaceutical things concept","volume":"20","author":"Hui","year":"2020","journal-title":"Sensors"},{"issue":"2","key":"10.1016\/j.sapharm.2021.12.004_bib28","article-title":"Enhancing pharmaceutical packaging through a technology ecosystem to facilitate the reuse of medicines and reduce medicinal waste","volume":"8","author":"Hui","year":"2020","journal-title":"Pharmacy (Basel)"},{"issue":"1","key":"10.1016\/j.sapharm.2021.12.004_bib29","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12913-019-4065-6","article-title":"What does it cost to redispense unused medications in the pharmacy? A micro-costing study","volume":"19","author":"Bekker","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.sapharm.2021.12.004_bib30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/0269216316639798","article-title":"Turning waste medicines to cost savings: a pilot study on the feasibility of medication recycling as a solution to drug wastage","volume":"31","author":"Toh","year":"2017","journal-title":"Palliat Med"},{"key":"10.1016\/j.sapharm.2021.12.004_bib31","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tmaid.2019.02.005","article-title":"Redispensing of unused HIV post-exposure prophylaxis for medical students","volume":"29","author":"Bekker","year":"2019","journal-title":"Trav Med Infect Dis"},{"issue":"2","key":"10.1016\/j.sapharm.2021.12.004_bib32","article-title":"Medicines as common commodities or powerful potions? What makes medicines reusable in people's eyes","volume":"9","author":"Chauhan","year":"2021","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.sapharm.2021.12.004_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/pharmacy9020085","article-title":"Stakeholder views on the idea of medicines reuse in the UK","volume":"9","author":"Donyai","year":"2021","journal-title":"Pharmacy"},{"issue":"5","key":"10.1016\/j.sapharm.2021.12.004_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-024767","article-title":"Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey","volume":"9","author":"Bekker","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.sapharm.2021.12.004_bib35","first-page":"12","article-title":"Beliefs and intentions towards reusing medicines in the future: a large\u2010scale, cross\u2010sectional study of patients in the UK","volume":"26","author":"Alhamad","year":"2018","journal-title":"Int J Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2021.12.004_bib36","article-title":"Public attitudes towards medicinal waste and medicines reuse in a 'free prescription' healthcare system","volume":"9","author":"McRae","year":"2021","journal-title":"Pharmacy (Basel)."},{"issue":"3","key":"10.1016\/j.sapharm.2021.12.004_bib37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3390\/pharmacy9030128","article-title":"The effect of quality indicators on beliefs about medicines reuse: an experimental study","volume":"9","author":"Lam","year":"2021","journal-title":"Pharmacy"},{"key":"10.1016\/j.sapharm.2021.12.004_bib38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"issue":"6","key":"10.1016\/j.sapharm.2021.12.004_bib39","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"5","key":"10.1016\/j.sapharm.2021.12.004_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28216","article-title":"Applying the COM-B model to patient-reported barriers to medication adherence in pediatric acute lymphoblastic leukemia","volume":"67","author":"Heneghan","year":"2020","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"10.1016\/j.sapharm.2021.12.004_bib41","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12913-020-05255-w","article-title":"Use of the theoretical domains framework and behaviour change wheel to develop a novel intervention to improve the quality of multidisciplinary cancer conference decision-making","volume":"20","author":"Fahim","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"5","key":"10.1016\/j.sapharm.2021.12.004_bib42","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s10488-013-0528-y","article-title":"Purposeful sampling for qualitative data collection and analysis in mixed method implementation research","volume":"42","author":"Palinkas","year":"2015","journal-title":"Adm Policy Ment Health"},{"key":"10.1016\/j.sapharm.2021.12.004_bib43","series-title":"Collecting and Interpreting Qualitative Materials","first-page":"375","article-title":"Focus groups: contingent articulations of pedagogy, politics, and inquiry","author":"Kamberelis","year":"2008"},{"issue":"4","key":"10.1016\/j.sapharm.2021.12.004_bib44","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","year":"2018","journal-title":"Qual Quantity"},{"issue":"13","key":"10.1016\/j.sapharm.2021.12.004_bib45","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1177\/1049732316654870","article-title":"Member checking: a tool to enhance trustworthiness or merely a nod to validation?","volume":"26","author":"Birt","year":"2016","journal-title":"Qual Health Res"},{"issue":"2","key":"10.1016\/j.sapharm.2021.12.004_bib46","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"3","key":"10.1016\/j.sapharm.2021.12.004_bib47","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0022242919825649","article-title":"How to shift consumer behaviors to be more sustainable: a literature review and guiding framework","volume":"83","author":"White","year":"2019","journal-title":"J Market"},{"issue":"3","key":"10.1016\/j.sapharm.2021.12.004_bib48","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/pubmed\/fdm037","article-title":"Returned medicines: waste or a wasted opportunity?","volume":"29","author":"Mackridge","year":"2007","journal-title":"J Publ Health"},{"issue":"2","key":"10.1016\/j.sapharm.2021.12.004_bib49","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.sapharm.2018.04.001","article-title":"Using the Behaviour Change Wheel to explore potential strategies for minimising harms from non-recreational prescription medicine sharing","volume":"15","author":"Beyene","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2021.12.004_bib50","series-title":"Directive 2011\/62\/EU of the European Parliament and the Council of the European Union","year":"2011"},{"issue":"7915","key":"10.1016\/j.sapharm.2021.12.004_bib51","first-page":"20","article-title":"Should pharmacists be allowed to reuse medicines?","volume":"301","author":"Connelly","year":"2018","journal-title":"The Pharmaceutical Journal A Royal Pharmaceutical Society Publication"},{"key":"10.1016\/j.sapharm.2021.12.004_bib52","series-title":"Novel Coronavirus (COVID-19) Standard Operating Procedure: Running a Medicines Re-use Scheme in a Care Home or Hospice Setting","author":"NHS England and NHS Improvement","year":"2020"},{"key":"10.1016\/j.sapharm.2021.12.004_bib53","series-title":"Trial NL9208: The ROAD to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs","year":"2021"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741121004034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741121004034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:27:28Z","timestamp":1761557248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741121004034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S1551741121004034"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.12.004","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key factors underlying the willingness of patients with cancer to participate in medication redispensing","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}